Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.
about
Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expressionSuppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cellsConditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell developmentGlobal transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cellsTherapeutic targets for HIV-1 infection in the host proteome.Manipulation of the host protein acetylation network by human immunodeficiency virus type 1Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a curePharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disordersNF-kappaB RelA phosphorylation regulates RelA acetylationTat-controlled protein acetylationModulation of NF-κB signalling by microbial pathogensAcetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.Acetylation of p65 at lysine 314 is important for late NF-kappaB-dependent gene expression.An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrateCombinatorial latency reactivation for HIV-1 subtypes and variantsRole of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alphaMass spectrometry-based proteomic approaches for discovery of HIV-host interactions.Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitineNF-kappaB and virus infection: who controls whom.Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits.ISSLS prize winner: inhibition of NF-κB activity ameliorates age-associated disc degeneration in a mouse model of accelerated aging.Impact of Tat Genetic Variation on HIV-1 DiseaseTherapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.Paradoxical enhancement of fear extinction memory and synaptic plasticity by inhibition of the histone acetyltransferase p300NF-kappa B-mediated adaptive resistance to ionizing radiation.Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65Assays for pharmacodynamic analysis of histone deacetylase inhibitors.The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB.HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.Regulation of HIV-1 latency by T-cell activation.Post-translational Serine/Threonine Phosphorylation and Lysine Acetylation: A Novel Regulatory Aspect of the Global Nitrogen Response Regulator GlnR in S. coelicolor M145.Specification of DNA binding activity of NF-kappaB proteinsThe anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes.AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoterMolecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
P2860
Q24289242-E05E0DF6-C0E6-46BB-BAFF-30E9A382D2B7Q24294541-FA841C54-4E37-47CB-A362-1E770AE7FAC9Q24537650-96BB660E-702A-456D-B27A-89343CC69595Q24685650-592BE605-9100-452F-9B92-B1AD1F9618A8Q24795470-E16D1551-A93B-433B-9B2F-97E4E166FE0FQ26795463-D7A0B037-4E89-4439-90D5-FAAA7EB17271Q26999858-44092B29-C325-4C69-8EBB-BAA35C30408CQ27006437-F14CFD33-A8B7-4681-A916-5F0FE988F22BQ28115098-72577E1E-C8F4-4E19-8E6B-1917BDAB5D32Q28216737-190DB392-FA93-421A-BD76-A4AEF8CD928BQ28709497-99265229-44FB-489D-8892-74422D5919F3Q33236503-A469527D-AABC-4A3F-B55E-BFD5A0C47FABQ33523177-3F9F5A6F-DF89-4A81-8C16-B9B807E38C55Q33717717-D1658412-D484-4012-B2ED-9447431EC184Q33877492-AEA0D7AA-41E5-41CC-847F-BAC335910C57Q34098320-C3E55CE1-65DB-4AC5-87D2-CB08F0E068D5Q34775632-B7D254F2-125B-4FB9-8616-04CB0AABF670Q34819481-8CFC1DD5-48A9-48E9-BD64-E1D02C3F5412Q34997110-2FCCA7EF-EB25-4535-A3E8-917DA28133C9Q35139535-EE096390-B574-4556-8099-F53E9327FF01Q35604870-3E15D31C-368E-4348-A590-02227FB4BC55Q36013236-24BE2592-43A7-426F-9A6E-9B71FB696776Q36092135-8AC3A049-FEDC-4DD5-B864-A06DCD881429Q36148507-C1AC63F6-A88B-43BB-B43A-86B2333E9A11Q36202761-35A25BE4-8E77-472E-86E9-61B61661BB2BQ36281272-A69D2AFC-88BF-4941-9B5E-27F517659275Q36493029-8CB75B53-1C3A-4CCF-9596-4FE60D8FD7B2Q36509262-BF2AA333-4574-4DDB-9AE1-623A18FD1063Q36546255-DE8E1A4E-F499-4A12-941E-2FCE9DAA20CCQ36668708-27900DD8-AB35-4790-8672-CB775A97DBABQ36668758-726328BD-8E71-4FEF-B942-C72C9158C99EQ36698389-5350C9F5-9564-4BE7-A6B8-9C6440964949Q36827396-13341FF1-856D-4A33-A9BA-4DFABCDCE3E2Q36887625-5461DA85-A4D9-43BA-A8B2-13AF7D2E7D2BQ37160425-71D22707-0283-4A95-945B-30487A52B162Q37412645-1A3C5D6B-121E-4CED-A983-FC2E02B7EAD3Q37510883-8A6A48BF-BAD5-4EC6-A971-F5EDA2FE852CQ37592555-C47E5E6B-D34A-4D28-9AA6-F02113AFB34EQ37596980-FE0C5765-3D9B-4814-ABE2-1D9A3D2478A2Q37644561-4533EC8E-E27C-4292-88E6-F3522364A8AE
P2860
Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Enhancement of nuclear factor- ...... r p300 and HIV-1 Tat proteins.
@en
type
label
Enhancement of nuclear factor- ...... r p300 and HIV-1 Tat proteins.
@en
prefLabel
Enhancement of nuclear factor- ...... r p300 and HIV-1 Tat proteins.
@en
P2093
P2860
P356
P1476
Enhancement of nuclear factor- ...... or p300 and HIV-1 Tat proteins
@en
P2093
Bansri Furia
Fatah Kashanchi
Kylene Kehn
Longwen Deng
Robert Donnelly
Shanese Baylor
Tim Coleman
P2860
P304
P356
10.1074/JBC.M107848200
P407
P50
P577
2001-12-05T00:00:00Z